New weight loss shot tested in humans for first time
NCT ID NCT06737536
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested a new medicine called NNC0662-0419 in 100 adults who are overweight or obese. The main goal was to check if the drug is safe and how the body handles it. Participants received either the drug or a placebo as a weekly injection under the skin. This is the first time this medicine has been given to people.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- NNC0662-0419
- What this could lead to
- If this early trial shows the drug is safe, it could lead to a new weekly injection for weight management.
- What could go wrong
- This is a very early Phase 1 study with only 100 people. Many drugs fail at this stage, and it will take years to know if it works for weight loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Celerion, Lincoln
Lincoln, Nebraska, 68502, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?